Pharma: Other News To Note
Monday, April 2, 2012
HTG Molecular Diagnostics, of Tucson, Ariz. established a collaborative program with Bridgewater, N.J.- based Sanofi US, part of Sanofi SA, to identify biomarkers that may lead to the development of a molecular companion diagnostic test to help identify patients most likely to respond to an unidentified Sanofi investigational agent.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.